Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREMOR study of switching tacrolimus-treated kidney transplant recipients with tremor to Envarsus or Neoral
NL-OMON43508Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus and cyclosporine in kidney transplant (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Tremor measured by ANT Pursuit and Tracking modules. Started Aug 2016; status: active, not recruiting.
02
Drugs
tacrolimuscyclosporine
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON43508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43508.